M.D. Anderson Cancer Center
Medicine/Pediatrics
Dr. Amin M. Alousi, MD
|
|
Give Review
Amin Alousi works in the field of Medicine/Pediatrics. He studied medicine at Wayne State University School of Medicine. Wayne State University School of Medicine has a rank of 63 in research and a 85 in primary care Amin Alousi is a published doctor and has 70 publications published. The lastest was: 'Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Pure Red Cell Aplasia in Major ABO Mismatched Allogeneic Hematopoietic Stem Cell Transplantation is Associated with Severe Pancytopenia.
- Vorinostat Combined with High-Dose Gemcitabine, Busulfan, and Melphalan with Autologous Stem Cell Transplantation in Patients with Refractory Lymphomas.
- A Refined Risk Score for Acute Graft-versus-Host Disease that Predicts Response to Initial Therapy, Survival, and Transplant-Related Mortality.
- Enforced fucosylation of cord blood hematopoietic Cells accelerates neutrophil and platelet engraftment after transplantation.
- Phase II Trial of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide after Reduced-Intensity Busulfan/Fludarabine Conditioning for Hemato...
- A PROGNOSTIC SCORE FOR Acute GRAFT-VERSUS-HOST DISEASE BASED ON BIOMARKERS: A MULTICENTER STUDY.
- Comparison of Survival in Patients with T Cell Lymphoma after Autologous and Allogeneic Stem Cell Transplantation as a Frontline Strategy or in Relapsed Disease.
- Cytogenetics, Donor Type, and Use of Hypomethylating Agents in Myelodysplastic Syndrome with Allogeneic Stem Cell Transplantation.
- BFR (bendamustine, fludarabine, and rituximab) allogeneic conditioning for chronic lymphocytic Leukemia/lymphoma: reduced myelosuppression and GVHD.
- Similar Transplantation Outcomes for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients with Haploidentical versus 10/10 Human Leukocyte Antigen-Matched Unre...
- Regulatory B Cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD.
- Phase III clinical trial steroids/mycophenolate mofetil vs steroids/placebo as therapy for Acute graft-versus-host disease: BMT CTN 0802.
- Is there an expiration date for a cord blood unit in storage?
- Complement component C3 mediates Th1/Th17 polarization in human T-Cell activation and cutaneous GVHD.
- The development of a myeloablative, reduced-toxicity, conditioning regimen for cord blood transplantation.
- The Effect of Peritransplant Minimal Residual Disease in Adults With Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
- Lenalidomide-Induced Graft-Vs.-Leukemia Effect in a Patient With Chronic Lymphocytic Leukemia Who Relapsed After Allogeneic Stem Cell Transplant.
- Extracorporeal photopheresis in the treatment of Graft-versus-host disease: evidence and opinion.
- Just-in-time rescue plerixafor in combination with chemotherapy and granulocyte-colony stimulating factor for peripheral blood progenitor Cell mobilization.
- Cytarabine, Ki-67, and SOX11 in patients with mantle Cell lymphoma receiving rituximab-containing autologous stem Cell transplantation during first remission.
- Outcomes of adults with Acute lymphoblastic leukemia (ALL) following relapse post allogeneic hematopoietic stem cell transplantation (HSCT).
- Lymphocyte Phenotype during Therapy for Acute Graft-versus-Host Disease: A Brief Report from BMT-CTN 0302.
- High-dose chemotherapy and Autologous Stem Cell Transplantation For Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL).
- Augmentation of blood dendritic Cells by extracorporeal photopheresis in patients with leukemic cutaneous T-Cell lymphoma and graft-versus-host disease.
- Graft-versus-host disease: state of the science.
- Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?
- Incidence and natural history of pure red Cell aplasia in major ABO-mismatched haematopoietic Cell transplantation.
- Cord-blood engraftment with ex vivo mesenchymal-Cell coculture.
- Autologous Stem Cell Transplantation for Refractory or Poor-Risk Relapsed Hodgkin Lymphoma: Effect of the Specific High-Dose Chemotherapy Regimen on Outcome.
- High-dose infusional gemcitabine combined with busulfan and melphalan with autologous stem-Cell transplantation in patients with refractory lymphoid malignancies.
- Improved Early Outcomes Using a T Cell Replete Graft Compared with T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplant.
- Clofarabine Combined with Busulfan Provides Excellent Disease Control in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Stem Cell...
- Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.
- Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular Lymphoma: 12-year results.
- Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of Graft-versus-host disease.
- Graft-versus-host disease: Part II. Management of cutaneous Graft-versus-host disease.
- Gemcitabine, fludarabine and melphalan as a reduced-intensity conditioning regimen for allogeneic stem Cell transplant in relapsed and refractory Hodgkin lymphoma: pre...
- Role of ERCP in patients after hematopoietic stem Cell transplantation.
- Platelet Recovery Prior to Allogeneic Stem Cell Transplant Predicts Posttransplant Outcomes in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome.
- Mesenchymal stem Cells in ex vivo cord blood expansion.
- The role of B Cell depleting therapy in graft versus host disease after allogeneic hematopoietic Cell transplant.
- Graft-versus-host disease treatment: predictors of survival.
- Economic evaluation of aromatase inhibitors for the treatment of Breast cancer.
- Nonmyeloablative allogeneic stem cell transplantation for chronic myelogenous Leukemia in the imatinib era.
- Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for Acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Tr...
- Autologous hematopoietic stem Cell transplantation may reverse renal failure in patients with multiple myeloma.
- Impairment of filgrastim-induced stem Cell mobilization after prior lenalidomide in patients with multiple myeloma.
- Disease staging with positron emission tomography or gallium scanning and use of rituximab predict outcome for patients with diffuse large B-Cell lymphoma treated with...
- Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in Myeloma patients undergoing an autotransplant.
- Reduced-intensity conditioning allogeneic hematopoietic stem Cell transplantation.
- A phase 1 trial of XK469: toxicity profile of a selective topoisomerase IIbeta inhibitor.
- Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR.
- Prognostic value of response after upfront therapy for Acute GVHD.
- Autologous stem Cell transplantation is safe and feasible in elderly patients with multiple myeloma.
- Reduced-intensity allogeneic hematopoietic stem Cell transplantation for relapsed multiple myeloma.
- A phase III study of infliximab and corticosteroids for the initial treatment of Acute graft-versus-host disease.
- Mycophenolate pharmacokinetics and association with response to Acute graft-versus-host disease treatment from the Blood and Marrow Transplant Clinical Trials Network.
- Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement.
- Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid Leukemia.
- Poor hematopoietic stem Cell mobilizers: a single institution study of incidence and risk factors in patients with recurrent or relapsed lymphoma.
- Eight-year experience with allogeneic stem Cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide...
- Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial.
- Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid Leukemia and MDS.
- Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle Cell lymphoma.
- Prophylaxis of Graft-versus-host disease in unrelated donor transplantation with pentostatin, tacrolimus, and mini-methotrexate: a phase I/II controlled, adaptively ra...
- High incidence of vitamin D deficiency in patients undergoing allogeneic stem Cell transplantation.
- High-dose chemotherapy and autologous hematopoietic progenitor Cell transplantation for non-Hodgkin''s lymphoma in patients >65 years of age.
- A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem Cells in patients with non-Ho...
- Steroid-Refractory Acute GVHD: Predictors and Outcomes.
Schools
Wayne State Univ Som
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Basal Cell Carcinoma
- Breast Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Medicine/Pediatrics
Accepted Insurances
Education
-
Wayne State University School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1023118015 | |
| NPPES Provider LastName | ALOUSI | |
| NPPES Provider FirstName | AMIN | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 633.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 39.0 | |
| Percent Opioid Claims | 6.16 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1023118015 |
| Last Name Of The Provider | ALOUSI |
| First Name Of The Provider | AMIN |
| View All |
Similar Doctors
|
|
Dr. Joseph A. Ludwig IV, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tara Barto, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth J. Shpall, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Shi-Ming Tu, MD |
|
|
Dr. Paulo M. Hoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria A. Scouros, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Wagner, MD |
|
|
Dr. Bilal Omer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neill R. White, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Keely L. Smith, MD
This Doctor is OpenDoctor Recommended.
|